Literature DB >> 15216075

COMPARATIVE HEMODYNAMIC EFFECTS OF NALBUPHINE AND MORPHINE IN PATIENTS WITH CORONARY ARTERY DISEASE.

Alexander Romagnoli1, Arthur S. Keats.   

Abstract

Entities:  

Year:  1978        PMID: 15216075      PMCID: PMC287700     

Source DB:  PubMed          Journal:  Cardiovasc Dis        ISSN: 0093-3546


× No keyword cloud information.
  6 in total

1.  Hemodynamic effects of morphine and pentazocine differ in cardiac patients.

Authors:  E L Alderman; W H Barry; A F Graham; D C Harrison
Journal:  N Engl J Med       Date:  1972-09-28       Impact factor: 91.245

2.  Evaluation of nalbuphine for abuse potential.

Authors:  D R Jasinski; P A Mansky
Journal:  Clin Pharmacol Ther       Date:  1972 Jan-Feb       Impact factor: 6.875

3.  Haemodynamic effects of pentazocine following acute myocardial infarction.

Authors:  A F Rickards; C S Smithen; E Sowton
Journal:  Ann Clin Res       Date:  1971-08

4.  Cardiovascular response to large doses of intravenous morphine in man.

Authors:  E Lowenstein; P Hallowell; F H Levine; W M Daggett; W G Austen; M B Laver
Journal:  N Engl J Med       Date:  1969-12-18       Impact factor: 91.245

5.  Haemodynamic effects of morphine in patients with acute myocardial infarction.

Authors:  M Thomas; R Malmcrona; S Fillmore; J Shillingford
Journal:  Br Heart J       Date:  1965-11

6.  Circulatory effects of intravenous pentazocine in patients with acute myocardial infarction.

Authors:  M E Scott; A A Adgey
Journal:  Curr Ther Res Clin Exp       Date:  1971-02
  6 in total
  6 in total

Review 1.  Adult sedation: oral, rectal, IM, IV.

Authors:  J A Giovannitti; L D Trapp
Journal:  Anesth Prog       Date:  1991 Jul-Oct

2.  The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects.

Authors:  M W Lo; F H Lee; W L Schary; C C Whitney
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Experience with nalbuphine, a new opioid analgesic, in acute myocardial infarction.

Authors:  R A Greenbaum; G Kaye; P D Mason
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

4.  Increase in cerebrospinal fluid pressure in normocapnic volunteers in response to nalbuphine.

Authors:  A Benzer; R Hüssler; L Russegger; A Faserl; D Balogh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  A comparison of nalbuphine and meperidine in treatment of postoperative pain.

Authors:  E Hew; K Foster; R Gordon; E Hew-Sang
Journal:  Can J Anaesth       Date:  1987-09       Impact factor: 5.063

Review 6.  Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  J K Errick; R C Heel
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.